Yongan Wang

Prof. Yongan Wang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
SYShun Yao
Shun Yao
JCJunjie Chi
Junjie Chi
YWYuetong Wang
Yuetong Wang
YZYuanjin Zhao
Yuanjin Zhao
YLYuan Luo
Yuan Luo
YWYongan Wang
Yongan Wang

16 November 2021 in Advanced Science
Verified
Journal Article
Open access
PDF file
SYShun Yao
Shun Yao
YWYuetong Wang
Yuetong Wang
JCJunjie Chi
Junjie Chi
YYYunru Yu
Yunru Yu
YZYuanjin Zhao
Yuanjin Zhao
YWYongan Wang
Yongan Wang
Patches with the capacity of controllable delivering active molecules toward the wound bed to promote wound healing are expectant all along. Herein, a novel porous metal‐organic framework (MOF) microneedle (MN) patch enabling photothermal‐responsive nitric oxide (NO) delivery for promoting diabetic wound healing is presented. As the NO‐loadable copper‐benzene‐1,3,5‐tricarboxylate (HKUST‐1) MOF is encapsulated with graphene oxide (GO), the resultant NO@HKUST‐1@GO microparticles (NHGs) are imparted with the feature of near‐infrared ray (NIR) photothermal response, which facilitate the controlled release of NO molecules. When these NHGs are embedded in a porous PEGDA‐MN, the porous structure, larger specific surface area, and sufficient mechanical strength of the integrated MN could promote a more accurate and deeper delivery of NO molecules into the wound site. By applying the resultant NHG‐MN to the wound of a type I diabetic rat model, the authors demonstrate that it is capable of accelerating vascularization, tissue regeneration, and collagen deposition, indicating its bright prospect applied in wound healing and other therapeutic scenarios.

1 July 2021 in Pharmacological Research
Verified
Journal Article
Closed access
MSMingyao Sun
Mingyao Sun
YSYangyang Sun
Yangyang Sun
ZFZiru Feng
Ziru Feng
XKXinliang Kang
Xinliang Kang
WYWeijie Yang
Weijie Yang
YLYuan Luo
Yuan Luo

1 May 2014 in Brain Research
Verified
Journal Article
Closed access
YLYuan Luo
Yuan Luo
YYYi-Ping Yang
Yi-Ping Yang
JLJie Liu
Jie Liu
WLWan-Hua Li
Wan-Hua Li
JYJun Yang
Jun Yang
YWYongan Wang
Yongan Wang

1 January 2021 in Journal of Controlled Release
Verified
Journal Article
Closed access
YZYadan Zhang
Yadan Zhang
JHJunlin He
Junlin He
LSLiao Shen
Liao Shen
TWTao Wang
Tao Wang
JYJun Yang
Jun Yang
DQDongqin Quan
Dongqin Quan

14 December 2015 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JYJun Yang
Jun Yang
LFLixue Fan
Lixue Fan
FWFeijian Wang
Feijian Wang
YLYuan Luo
Yuan Luo
XSXin Sui
Xin Sui
YWYongan Wang
Yongan Wang
The toxic nerve agent (NA) soman is the most toxic artificially synthesized compound that can rapidly penetrate into the brain and irreversibly inhibit acetylcholinesterase (AChE) activity, leading to immediate death. However, there are currently few brain-targeted nanodrugs that can treat acute chemical brain poisoning owing to the limited drug-releasing speed. The present study investigated the effectiveness of a nanodrug against NA toxicity that has high blood–brain barrier penetration and is capable of rapid drug release. Transferrin-modified mesoporous silica nanoparticles (TF-MSNs) were conjugated with the known AChE reactivator HI-6. This nanodrug rapidly penetrated the blood–brain barrier in zebrafish and mice and restored cerebral AChE activity via the released HI-6, preventing the brain damage caused by soman poisoning and increasing the survival rate in mice. Furthermore, there was no toxicity associated with the MSNs in mice or rats. These results demonstrate that TF-MSNs loaded with HI-6 represent the most effective antidote against NA poisoning by soman reported to date, and suggest that MSNs are a safe alternative to conventional drugs and an optimal nanocarrier for treating brain poisoning, which requires acute pulse cerebral administration.